Published in
Springer Nature [academic journals on nature.com], British Journal of Cancer, 1(112), p. 52-60, 2014
DOI: 10.1038/bjc.2014.563
Links
- ORCID
- Springer Nature [academic journals on nature.com] | PDF
- [arts.units.it] | PDF
- [europepmc.org] | PDF
- [www.researchgate.net] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
Tools
Combination of letrozole, metronomic cyclophosphamide and sorafenib is well-tolerated and shows activity in patients with primary breast cancer
Journal article published in 2014 by
L. Bazzola,
C. Foroni,
D. Andreis 
,
V. Zanoni,
M. R. Cappelletti,
M. R. Cappelletti,
G. Allevi,
S. Aguggini,
C. Strina,
M. Milani,
S. Venturini,
F. Ferrozzi,
R. Giardini,
R. Bertoni,
H. Turley
and other authors.
,
V. Zanoni,
M. R. Cappelletti,
M. R. Cappelletti,
G. Allevi,
S. Aguggini,
C. Strina,
M. Milani,
S. Venturini,
F. Ferrozzi,
R. Giardini,
R. Bertoni,
H. Turley
and other authors.
This paper is available in a repository.
Full text: Download
Published version:
archiving forbidden
Data provided by 